Melanotan 2 (MT-2) 10mg

Melanotan 2 (MT-2)

Melanotan 2 (MT-2) 10mg Melanotan 2 ( MT-2 ) is a synthetic peptide derived from the natural melanocortin α-MSH , a key molecule in the control of pigmentation, energy homeostasis, feeding behavior, and numerous neuroendocrine functions. Designed as a variant of Melanotan 1, MT-2 interacts with several melanocortin receptors, non-selectively mimicking some of the physiological mechanisms of α-MSH. Studies initiated at the University of Arizona in the 1980s highlighted its impact on melanin production and sunless tanning, but research has since expanded its scope to analyze its effects on behavioral functions, appetite, glucose regulation, sexual drive, and even specific behavioral patterns associated with autism spectrum disorders.

Melanotan 2 (MT-2) 10mg MT-2 is currently one of the most studied peptides within the melanocortin family. Its scientific value lies not only in its pigmenting effect, but above all in its ability to modulate complex neurobiological pathways involving oxytocin, leptin, glucagon, and numerous hypothalamic signals. This makes it a useful experimental model for better understanding physiological dynamics such as hunger, compulsive behavior, weight regulation, stress response, and social processes.

---

Mechanism of action on melanocortin receptors

The effect of MT-2 is mediated primarily by the MC-1R , MC-3R , and MC-4R receptors . Activation of MC-1R in melanocytes stimulates the synthesis of eumelanin, leading to increased skin and hair pigmentation through increased melanogenesis activity. It is this mechanism that has made MT-2 popular as an experimental pigmentation agent, due to its ability to increase pigment density without exposure to UV light.

MT-2 then binds to the MC-4R receptors, located primarily in the hypothalamus. This interaction is associated with changes in eating behavior, modulation of the sexual response, and increased energy expenditure through thermogenesis. MC-4R is among the most studied receptors involved in appetite regulation; genetic mutations that compromise its function are among the most well-known causes of severe childhood obesity. MT-2, thanks to its agonist activity, has become a useful model for analyzing the differences between normal and attenuated melanocortin signaling.

The MC-3R receptor, also activated by MT-2, participates in the regulation of energy homeostasis and feeding motivation. Although its role is less well-defined than that of MC-4R, its presence in brain regions involved in body weight regulation suggests that it contributes to the peptide’s overall effects on satiety and metabolic balance.

---

Impact on social behaviors and patterns of autism

One of the most innovative areas of research concerns the relationship between MT-2 and behaviors associated with autism spectrum disorders. In a mouse model of maternal immune activation , in which puppies develop reduced sociability, poor vocal communication, and repetitive behaviors, administration of Melanotan 2 resulted in a marked improvement in social interactions. This effect has been linked to increased expression of oxytocin receptors in brain regions involved in communication and the development of interpersonal relationships.

Oxytocin is a key molecule for social behavior, trust, and group cohesion. MT-2’s ability to enhance this biological pathway has helped establish a link between the melanocortin system and social modulation, paving the way for new hypotheses on the physiology of social interactions and the neural circuits governing empathy and affiliation.

---

Regulation of appetite, satiety and eating behavior

The literature confirms that MT-2 plays a significant role in modulating appetite. Its interaction with MC-4R in the hypothalamus reduces food intake and induces changes in food preferences, particularly a decrease in interest in high-fat foods. It has been shown that individuals with inactivating mutations of this receptor tend to consume significantly greater amounts of high-fat foods, suggesting that melanocortin signaling functions as a key regulator of food preferences.

MT-2 also acts on the leptin pathway. Leptin is known as the “satiety hormone,” but its pharmacological efficacy is limited by its reduced ability to cross the blood-brain barrier. MT-2, on the other hand, penetrates the central nervous system more easily and can activate satiety pathways more extensively, modulating the expression of the TRH gene and influencing the hypothalamic nuclei that control hunger and body weight.

---

Role in glucose metabolism and diabetes physiology

Extensive studies have shown that MT-2 can modulate glucose regulation through the activation of melanocortin receptors in the central nervous system. Injection of the peptide into the ventromedial hypothalamus increases glucose uptake in skeletal muscle, heart, and brown adipose tissue (BAT), improving glycemic control. These findings are relevant to diabetes research, as they suggest that MT-2 may have therapeutic potential in the treatment of diabetes by directly affecting glucose regulation in the central nervous system.

Other studies suggest that activating melanocortin receptors may reduce the excessive production of glucagon, a hormone associated with high blood glucose levels. Modulating this pathway could be particularly useful for treating type 2 diabetes, in which overproduction of glucagon contributes to insulin resistance.

---

Impulsive behavior and alcohol intake

The effect of MT-2 on impulsive behavior has also been evaluated in the context of alcohol consumption. In animal models, the peptide significantly reduces ethanol consumption, while simultaneously increasing water intake. This effect has been attributed to the activation of MC-4R receptors in limbic regions, particularly the amygdala. Subsequent studies have highlighted a significant synergy between MT-2 and naltrexone, with a marked increase in the latter’s effectiveness in reducing binge drinking episodes. These findings open avenues for research into the brain mechanisms regulating motivation and craving.

---

Sexual functions and erection

Another widely studied area concerns sexual function. Activation of MC-4R and other central neural pathways by MT-2 has been associated with increased sexual arousal and a more pronounced erectile response. Controlled studies in men with psychogenic erectile dysfunction have shown significant physiological responses after administration of the peptide, with penile rigidity lasting longer than placebo. These findings have sparked interest in research on desire disorders and in understanding the neurobiological circuits underlying sexual response.